Is yawning and nausea a common early side effect of escitalopram in adults, and how should it be managed?

Yawning and Nausea with Escitalopram

Yes, both yawning and nausea are well-documented side effects of escitalopram, with nausea being very common (15-18% incidence) and yawning less common but clinically significant (2% in controlled trials). 1

Nausea: A Common Early Side Effect

Nausea is the most frequently reported adverse effect of escitalopram and the most common reason for treatment discontinuation in clinical trials. 2, 3

Key characteristics:

• Incidence: 15% in major depressive disorder trials and 18% in generalized anxiety disorder trials (compared to 7-8% with placebo) 1
• Timing: Typically occurs early in treatment and is usually transient 4
• Severity: Generally mild to moderate 5
• Discontinuation rate: Approximately 2% of patients stop escitalopram specifically due to nausea 1

Yawning: A Less Common but Recognized Side Effect

Yawning is explicitly listed in the FDA label as a side effect, though less frequently discussed. 1

Key characteristics:

• Incidence: 2% in generalized anxiety disorder trials (compared to 1% with placebo) 1
• Mechanism: Related to serotonergic effects on neurotransmitter systems 6
• Pattern: Can occur with stable dosing after weeks of treatment, not just at initiation 7
• Dose-relationship: May increase with higher doses 8

Important distinction: Yawning in depression itself is common due to disturbed sleep and fatigue. The key differentiator is that SSRI-induced yawning is typically excessive, occurs during daytime without associated sedation or need for sleep, and correlates with treatment response patterns. 9

Management Algorithm

For Nausea:

1. Reassure and continue treatment - Nausea is typically transient and resolves within 1-2 weeks 4
2. Take with food - Can reduce gastrointestinal side effects
3. If severe or persistent beyond 2 weeks:
   • Consider dose reduction temporarily, then re-titrate
   • If intolerable, switch to alternative SSRI with lower nausea rates (sertraline or paroxetine have similar profiles; consider mirtazapine which has antiemetic properties) 3

For Yawning:

1. Assess severity and impact on social/occupational functioning 8
2. If mild: Monitor and reassure - may resolve spontaneously
3. If bothersome:
   • Reduce dose - Case reports show yawning can disappear within hours of dose reduction without depression recurrence 7
   • If dose reduction inadequate or causes symptom return, consider switching to non-SSRI antidepressant (bupropion or mirtazapine) 3

Critical Clinical Pitfalls

Do not assume yawning is just residual depression symptoms - If yawning emerges or worsens after starting escitalopram, particularly if excessive and without sleepiness, it is likely medication-induced. 9

Do not prematurely discontinue for nausea - Most patients who persist through the first 1-2 weeks will see nausea resolve completely. The 10 mg dose has similar efficacy to 20 mg with significantly lower discontinuation rates (4% vs 10%). 1

Monitor for dose-dependent effects - The 20 mg dose has approximately twice the rate of common side effects including nausea (14% vs 6%), dizziness (7% vs 4%), and somnolence (9% vs 4%) compared to 10 mg. 1

Evidence Quality Note

The nausea data comes from high-quality, placebo-controlled trials with over 4,000 patients across multiple indications. 5 The yawning data is less robust, primarily from FDA label reporting and case series, though a recent 2026 prospective study confirmed increased yawning prevalence from 5.4% to 15.4% post-SSRI treatment. 9 Both side effects are well-established in clinical practice despite yawning being underreported in formal trials. 6